Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk

Recent advances in proteomic technologies have made high-throughput profiling of low-abundance proteins in large epidemiological cohorts increasingly feasible. We investigated whether aptamer-based proteomic profiling could identify biomarkers associated with future development of type 2 diabetes (T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JCI Insight
Autores principales: Ngo, Debby, Benson, Mark D., Long, Jonathan Z., Chen, Zsu-Zsu, Wang, Ruiqi, Nath, Anjali K., Keyes, Michelle J., Shen, Dongxiao, Sinha, Sumita, Kuhn, Eric, Morningstar, Jordan E., Shi, Xu, Peterson, Bennet D., Chan, Christopher, Katz, Daniel H., Tahir, Usman A., Farrell, Laurie A., Melander, Olle, Mosley, Jonathan D., Carr, Steven A., Vasan, Ramachandran S., Larson, Martin G., Smith, J. Gustav, Wang, Thomas J., Yang, Qiong, Gerszten, Robert E.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8021115/
https://ncbi.nlm.nih.gov/pubmed/33591955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.144392
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares